The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

Matthew J MacKay; Anna C Hooker; Ebrahim Afshinnekoo; Marc Salit; Jason Kelly; Jonathan V Feldstein; Nick Haft; Doug Schenkel; Subhalaxmi Nambi; Yizhi Cai; Feng Zhang; George Church; Junbiao Dai; Cliff L Wang; Shawn Levy; Jeff Huber; Hanlee P Ji; Alison Kriegel; Anne L Wyllie; Christopher E Mason

doi:10.1038/s41587-020-0655-4

The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

Matthew J MacKay, Anna C Hooker, Ebrahim Afshinnekoo, Marc Salit, Jason Kelly, Jonathan V Feldstein, Nick Haft, Doug Schenkel, Subhalaxmi Nambi, Yizhi Cai, Feng Zhang, George Church, Junbiao Dai, Cliff L Wang, Shawn Levy, Jeff Huber, Hanlee P Ji, Alison Kriegel, Anne L Wyllie, Christopher E Mason

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1021-1024
Number of pages	4
Journal	Nature biotechnology
Volume	38
Issue number	9
DOIs	https://doi.org/10.1038/s41587-020-0655-4
Publication status	Published - 20 Aug 2020

Keywords

Awards and Prizes
Betacoronavirus/isolation & purification
COVID-19
Coronavirus Infections/diagnosis
Humans
Pandemics
Pneumonia, Viral/diagnosis
SARS-CoV-2

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41587-020-0655-4

Cite this

MacKay, M. J., Hooker, A. C., Afshinnekoo, E., Salit, M., Kelly, J., Feldstein, J. V., Haft, N., Schenkel, D., Nambi, S., Cai, Y., Zhang, F., Church, G., Dai, J., Wang, C. L., Levy, S., Huber, J., Ji, H. P., Kriegel, A., Wyllie, A. L., & Mason, C. E. (2020). The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing. Nature biotechnology, 38(9), 1021-1024. https://doi.org/10.1038/s41587-020-0655-4

@article{8eb74dc6fe7a4ff2806555f50591d7c8,

title = "The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing",

keywords = "Awards and Prizes, Betacoronavirus/isolation & purification, COVID-19, Coronavirus Infections/diagnosis, Humans, Pandemics, Pneumonia, Viral/diagnosis, SARS-CoV-2",

author = "MacKay, {Matthew J} and Hooker, {Anna C} and Ebrahim Afshinnekoo and Marc Salit and Jason Kelly and Feldstein, {Jonathan V} and Nick Haft and Doug Schenkel and Subhalaxmi Nambi and Yizhi Cai and Feng Zhang and George Church and Junbiao Dai and Wang, {Cliff L} and Shawn Levy and Jeff Huber and Ji, {Hanlee P} and Alison Kriegel and Wyllie, {Anne L} and Mason, {Christopher E}",

year = "2020",

month = aug,

day = "20",

doi = "10.1038/s41587-020-0655-4",

language = "English",

volume = "38",

pages = "1021--1024",

journal = "Nature biotechnology",

issn = "1546-1696",

publisher = "Springer Nature",

number = "9",

}

MacKay, MJ, Hooker, AC, Afshinnekoo, E, Salit, M, Kelly, J, Feldstein, JV, Haft, N, Schenkel, D, Nambi, S, Cai, Y, Zhang, F, Church, G, Dai, J, Wang, CL, Levy, S, Huber, J, Ji, HP, Kriegel, A, Wyllie, AL & Mason, CE 2020, 'The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing', Nature biotechnology, vol. 38, no. 9, pp. 1021-1024. https://doi.org/10.1038/s41587-020-0655-4

TY - JOUR

T1 - The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

AU - MacKay, Matthew J

AU - Hooker, Anna C

AU - Afshinnekoo, Ebrahim

AU - Salit, Marc

AU - Kelly, Jason

AU - Feldstein, Jonathan V

AU - Haft, Nick

AU - Schenkel, Doug

AU - Nambi, Subhalaxmi

AU - Cai, Yizhi

AU - Zhang, Feng

AU - Church, George

AU - Dai, Junbiao

AU - Wang, Cliff L

AU - Levy, Shawn

AU - Huber, Jeff

AU - Ji, Hanlee P

AU - Kriegel, Alison

AU - Wyllie, Anne L

AU - Mason, Christopher E

PY - 2020/8/20

Y1 - 2020/8/20

KW - Awards and Prizes

KW - Betacoronavirus/isolation & purification

KW - COVID-19

KW - Coronavirus Infections/diagnosis

KW - Humans

KW - Pandemics

KW - Pneumonia, Viral/diagnosis

KW - SARS-CoV-2

U2 - 10.1038/s41587-020-0655-4

DO - 10.1038/s41587-020-0655-4

M3 - Article

C2 - 32820257

SN - 1546-1696

VL - 38

SP - 1021

EP - 1024

JO - Nature biotechnology

JF - Nature biotechnology

IS - 9

ER -